![stethoscope gavel lawbooks and caduceus](/sites/default/files/2019-09/stock-gavel-stethoscope-law-books-900x400.jpg)
Treatment with subcutaneous interferon beta-1a plus remdesivir was not superior to treatment with remdesivir alone in a clinical trial that enrolled 969 hospitalized adults with COVID-19 pneumonia in the United States, Japan, Mexico, Singapore and South Korea, the National Institutes of Health reported.